267 related articles for article (PubMed ID: 18612543)
1. Immune complex-mediated glomerulonephritis is ameliorated by thrombin-activatable fibrinolysis inhibitor deficiency.
Bruno NE; Yano Y; Takei Y; Qin L; Suzuki T; Morser J; D'Alessandro-Gabazza CN; Mizoguchi A; Suzuki K; Taguchi O; Gabazza EC; Sumida Y
Thromb Haemost; 2008 Jul; 100(1):90-100. PubMed ID: 18612543
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
[TBL] [Abstract][Full Text] [Related]
3. Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?
Bouma BN; Mosnier LO
Ann Med; 2006; 38(6):378-88. PubMed ID: 17008302
[TBL] [Abstract][Full Text] [Related]
4. An inhibitor of thrombin activated fibrinolysis inhibitor (TAFI) can reduce extracellular matrix accumulation in an in vitro model of glucose induced ECM expansion.
Atkinson JM; Pullen N; Johnson TS
Matrix Biol; 2013 Jun; 32(5):277-87. PubMed ID: 23369837
[TBL] [Abstract][Full Text] [Related]
5. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
Stasko J; Hudecek J; Kubisz P
Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterisation of monoclonal antibodies that impair the activation of human thrombin activatable fibrinolysis inhibitor through different mechanisms.
Mishra N; Vercauteren E; Develter J; Bammens R; Declerck PJ; Gils A
Thromb Haemost; 2011 Jul; 106(1):90-101. PubMed ID: 21544309
[TBL] [Abstract][Full Text] [Related]
7. Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients.
Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
Transplant Proc; 2006; 38(1):105-7. PubMed ID: 16504676
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-activatable fibrinolysis inhibitor protects against acute lung injury by inhibiting the complement system.
Naito M; Taguchi O; Kobayashi T; Takagi T; D'Alessandro-Gabazza CN; Matsushima Y; Boveda-Ruiz D; Gil-Bernabe P; Matsumoto T; Chelakkot-Govindalayathil AL; Toda M; Yasukawa A; Hataji O; Morser J; Takei Y; Gabazza EC
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):646-53. PubMed ID: 23721130
[TBL] [Abstract][Full Text] [Related]
9. [The TAFI system. The new role of fibrinolysis].
Dempfle CE
Hamostaseologie; 2007 Sep; 27(4):278-81. PubMed ID: 17938767
[TBL] [Abstract][Full Text] [Related]
10. Biochemical importance of glycosylation in thrombin activatable fibrinolysis inhibitor.
Buelens K; Hillmayer K; Compernolle G; Declerck PJ; Gils A
Circ Res; 2008 Feb; 102(3):295-301. PubMed ID: 18063813
[TBL] [Abstract][Full Text] [Related]
11. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy.
Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
Thromb Haemost; 2004 Mar; 91(3):480-6. PubMed ID: 14983223
[TBL] [Abstract][Full Text] [Related]
12. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
Boffa MB; Koschinsky ML
Clin Biochem; 2007 Apr; 40(7):431-42. PubMed ID: 17331488
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in rats.
Soni H; Sharma A; Bhatt S; Jain MR; Patel PR
Pharmacology; 2008; 82(4):304-9. PubMed ID: 18936552
[TBL] [Abstract][Full Text] [Related]
14. Thrombin activatable fibrinolysis inhibitor (TAFI): a role in pre-eclampsia?
Dusse LM; Cooper AJ; Lwaleed BA
Clin Chim Acta; 2007 Mar; 378(1-2):1-6. PubMed ID: 17184758
[TBL] [Abstract][Full Text] [Related]
15. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
Nielsen VG; Steenwyk BL; Gurley WQ
J Heart Lung Transplant; 2006 Oct; 25(10):1247-52. PubMed ID: 17045938
[TBL] [Abstract][Full Text] [Related]
16. Presence of thrombin-activatable fibrinolysis inhibitor in Helicobacter pylori-associated gastroduodenal disease.
Ikeda A; Gabazza EC; Morser J; Imoto I; Kuroda M; D'Alessandro-Gabazza CN; Hara K; Ruiz DB; Bernabe PG; Katsurahara M; Toda M; Kobayashi Y; Yano Y; Sumida Y; Suzuki K; Taguchi O; Takei Y
Helicobacter; 2009 Apr; 14(2):147-55. PubMed ID: 19298343
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitor.
Develter J; Dewilde M; Gils A; Declerck PJ
Thromb Haemost; 2009 Jul; 102(1):69-75. PubMed ID: 19572070
[TBL] [Abstract][Full Text] [Related]
18. [TAFI--thrombin activated fibrinolysis inhibitor ].
Hryszko T; Małyszko J; Brzósko S; Myśliwiec M
Przegl Lek; 2001; 58(3):136-8. PubMed ID: 11475860
[TBL] [Abstract][Full Text] [Related]
19. Comparison of effects of different heparins on thrombin activatable fibrinolysis inhibitor in hemodialyzed patients.
Małyszko J; Małyszko JS; Hryszko T; Pawlak K; Myśliwiec M
Am J Nephrol; 2004; 24(6):624-9. PubMed ID: 15627717
[TBL] [Abstract][Full Text] [Related]
20. [State of the thrombin-plasmin system in nephrotoxic nephritis treated with heparin, urokinase, and uroplasmin].
Monastyrskiĭ VA; Ambarova LI
Arkh Patol; 1980; 42(1):17-22. PubMed ID: 6445726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
